Clinical Trials Logo

Clinical Trial Summary

Symptomatic knee osteoarthritis is a serious public health problem in the world, it carries a high personal, social and economic impact. Currently, there are no drugs that modify the natural course of the disease. As analgesic therapy becomes insufficient, more invasive measures are applied, ultimately leading to arthroplasty. The scientific community has joined efforts to develop new therapeutic approaches that allow the delay and regeneration of injured tissue in these patients. These include cell therapy with mesenchymal stem cells derived from different sources. Although most of the clinical studies carried out in different parts of the world with this therapy in patients with knee osteoarthritis have shown therapeutic benefit, it is necessary to develop clinical trials with high quality in our population. The aim of this project is to evaluate the safety, tolerance and efficacy of Cellistem-OA (biological therapy based on mesenchymal stem cells derived from Wharton's jelly of umbilical cord) in patients with knee osteoarthritis in the Colombian population. Investigators proposed to carry out an experimental (clinical trial), randomized, controlled and parallel with 30 participants with knee knee osteoarthritis of the medical complex Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle. The participants will be randomized into two groups: i) 15 patients who will receive a dose of 2 x 106 Cellistem-OA and ii) 15 patients who will receive an active comparator (acetonide of triamcinolone 10mg / mL), which will be administered by intra-articular injection in the superolateral aspect of the knee. The outcomes to be evaluated will be: (i) decrease in joint pain, (ii) increase in joint functionality, (iii) improvement in quality of life and (iv) improvement of articular cartilage. These parameters will be evaluated at weeks 1, 4, 8, 12, 24, 25, 28, 32, 36 and 52 post-treatments. Additionally, local and systemic adverse events will be recorded to establish whether or not there is an association between them and the intervention.


Clinical Trial Description

Type of study Controlled, randomized, double-blind clinical trial comparing CELLISTEM-OA and active comparator (triamcinolone acetonide). Study population Patients from the Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle who consult the trauma and rheumatology service by knee osteoarthritis. Patients who show interest in participating will be cited to an interview with the researchers where both the objectives and the research procedures will be explained. Sample size The sample size considered are 30 participants distributed in two groups. Group 1 (control) active comparator: triamcinolone acetonide (10mg / mL) via intra-articular, 5 cc. Group 2 (experimental): CELLISTEM-OA via intra-articular, doses of 2 x 106 cells in 5cc of saline solution. The intra-articular puncture will be performed by an orthopedic doctor specializing in knee and hip treatments using sterile technique, after cooling the skin with local ice. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04863183
Study type Interventional
Source Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle
Contact Martha L Arango, PhD
Phone (57) 3226816547
Email [email protected]
Status Not yet recruiting
Phase Phase 1/Phase 2
Start date June 1, 2021
Completion date June 30, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04651673 - Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)
Active, not recruiting NCT04043819 - Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis Phase 1
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT04779164 - The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis N/A
Recruiting NCT04006314 - Platelet Rich Plasma and Neural Prolotherapy Injections in Treating Knee Osteoarthritis N/A
Enrolling by invitation NCT04145401 - Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK
Active, not recruiting NCT03781843 - Effects of Genicular Nerve Block in Knee Osteoarthritis N/A
Completed NCT04589858 - Effect of Manual Therapies With Supervised Exercise Protocol on Pain and Functional Disability in Patients With Knee OA N/A
Not yet recruiting NCT04331990 - The Distraction of Knee Joint to Alleviate osteoArthritic Pain (DiKAP) Trial N/A
Not yet recruiting NCT04547595 - Hypnosis Intervention for the Management of Pain Perception During Joint Lavage Phase 3
Not yet recruiting NCT03825965 - Cannabinoids vs. Placebo on Persistent Post-surgical Pain Following TKA: A Pilot RCT Phase 3
Not yet recruiting NCT04257682 - Regional Anesthesia in Total Hip and Knee Arthroplasty Phase 4
Not yet recruiting NCT04040764 - Uncemented Tritanium TKR vs Cemented Triathlon TKR N/A
Not yet recruiting NCT03628664 - Preoperative CT Assisted Planning for Primary Total Knee Arthroplasty N/A
Completed NCT02876120 - The STavanger osteoARThritis Study N/A
Recruiting NCT02563756 - Unicondylar- or Total Knee Replacement? Patient Satisfaction, Function and Muscle Mass N/A
Recruiting NCT02003976 - A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone N/A
Enrolling by invitation NCT02098070 - Knee Pain Phenotypes in the Community Study N/A
Completed NCT02416505 - The Age of OrthoInfo: A Randomized Controlled Trial Evaluating Patient Comprehension of Informed Consent N/A
Completed NCT03106142 - Knee Osteoarthritis Care: A Quality Improvement Intervention in General Practice N/A